Aug 2026· Journal of Translational Autoimmunity· Vol 13, pp. 100393· 0 citations· 123 references
Medicine
TL;DR
Using the latest scientific results, the present article provides the necessary theoretical basis for the implementation of precision medicine methods in the treatment of autoimmune skin diseases.
Abstract
Autoimmune skin diseases, including psoriasis, cutaneous forms of systemic lupus erythematosus, and scleroderma, involve complicated interactions between genetic and environmental factors. Modern developments have pointed out the importance of regulatory epigenetic processes associated with DNA methylation, histone lactylation, and different types of non-coding RNA molecules like miRNA, lncRNAs, and circRNAs. Epigenetic factors serve as a “pacemaker” for immune cell activation, keratinocytes' function disturbances, and inflammatory microenvironment reconstruction. This review covers the role of epigenetics in development and progression of autoimmune skin diseases and shows its potential use for diagnostics, prediction, and treatment of these pathological conditions. Using the latest scientific results, the present article provides the necessary theoretical basis for the implementation of precision medicine methods in the treatment of autoimmune skin diseases.
The essential roles that epigenetic modifications play in driving the pathogenesis of diverse dermatological disorders are delineated, as well as to highlight their clinical applications within current skin research, to comprehensively outlines the pivotal role of epigenetic modifications.
Ghadah Alhetheli· International Journal of Res...· 0 citations
Autoimmune diseases are complex disorders arising from interactions among genetic susceptibility, epigenetic regulation, and environmental exposures. Accumulating evidence indicates that DNA methylation, histone modifications, and non-coding RNAs (ncRNAs) may mediate some of the effects of environmental factors on immu...
Zaher Sabbagh, E. S. Aslan· EUCHEMBIOJ Reviews· 0 citations
Although preclinical studies have validated ASF1A as a promising prognostic biomarker and therapeutic target, relevant clinical trials supporting its clinical application remain absent.
Jun Yin, Xiao-Jian Zhuo, Li-Hui Wen et al.· Experimental and Therapeutic...· 0 citations
Abnormal epigenetic modifications are involved in central nervous system (CNS) diseases. Histones play a crucial role in chromatin structure and function, whose post-translational modifications significantly impact gene expression and chromatin dynamics. Histone acetylation, governed by the balance between histone acet...
Xiao-Ming Xin, Ling-Juan Wu, Mei-Chen Liu et al.· Frontiers in Molecular Neuro...· 0 citations
It is suggested that achieving durable therapeutic remission may require reprogramming pathogenic chromatin states rather than solely suppressing inflammatory pathways.
S. Bilik, Garrett Kraft, Isabella Sharifi et al.· Frontiers in Immunology· 0 citations
It is suggested that the interaction between epigenetic and epitranscriptomic mechanisms is a key factor in determining risk and resilience for neuropsychiatric disorders, and offers new directions for future research and therapy development.
Y. Dwivedi, B. Roy· Brain : a journal of neurolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.